EdwardsC. L., and HayesR. L.: Tumor Scanning with 67Ga Citrate, J. Nucl. Med.10: 103–105 (Feb.) 1969.
2.
EdwardsC. L., and HayesR. L.: Scanning Malignant Neoplasms with Gallium-67, J. Am. Med. Assoc.212: 1182–1190 (May 19) 1970.
3.
WinchellH. S.: Visualization of Tumors in Humans Using 67Ga Citrate and the Anger Whole-Body Scanner, Scintillation Camera, and Tomographic Scanner, J. Nucl. Med.11: 459–466 (July) 1970.
4.
VaidyaS. C.: Localization of Gallium-67 in Malignant Neoplasms, Lancet2: 911–914 (Oct. 31) 1970.
5.
LavenderJ. P.: Gallium-67 Citrate Scanning in Neoplastic and Inflammatory Lesions, Brit. J. Radiol.44: 361–366 (May) 1971.
6.
PinskyS. M.: (Abst.) Place of 67GA in the Staging of Hodgkin's Disease, J. Nucl. Med.12: 385 (June) 1971.
7.
ItoY.: Diagnostic Evaluation of 67Ga Scanning of Lung Cancer and other Diseases, Radiology101: 355–362 (Nov.) 1971.
8.
SuzukiT.: Positive Scintiphotography of Cancer of the Liver with Ga-67 Citrate, Am. J. Roentgenol Radium Ther. Nucl. Med.113: 92–103 (Sept.) 1971.
9.
HigasiT.: Clinical Evaluation of 67Ga Citrate Scanning, J. Nucl Med.13: 196–201 (Mar.) 1972.
10.
LanghammerH.: 67Ga for Tumor Scanning. J. Nucl. Med.13: 25–30 (Jan.) 1972.
11.
TurnerD. A.: The Use of 67Ga Scanning in the Staging of Hodgkin's Disease, Radiology103: 97–101 (June) 1972.
12.
KayD. N., and McCreadyR. V.: Clinical Isotope Scanning Using 67Ga Citrate in the Management of Hodgkin's Disease, Brit. J. Radiol.45: 437–443 (June) 1972.
13.
LomasF., DibosP. E., and WagnerH. N.: Increased Specificity of Liver Scanning with the Use of 67Gallium Citrate, N. E. J. Med.286: 1312–1329, June 22, 1972.
14.
DudleyH. C.: Gallium Citrate and Radio-Gallium (Ga-72) Citrate, J. Amer. Chem. Soc.72: 3822–3823 (Aug.) 1950.
15.
Gallium-67, as the Citrate, for Intravenous Administration, Product Monograph, New England Nuclear Corporation, Boston, Massachusetts.
16.
HartmanR. F., and HayesR. L.: Gallium Binding by Blood Serum, (Abst) Fed Proc26: 780 (Mar.) 1967.
17.
ItoY.: 67Ga Tumor Scanning and Its Mechanism Studied in Rabbits, Radiology100: 357–362 (Aug.) 1971.
18.
Personal Communication, Diagnostic Isotopes, Upper Saddle River, New Jersey.
19.
BrunerH. D., HayesR. L., PerkinsonJ. D.Jr.: A Study of Gallium X. Preliminary Data in Gallium67, Radiology61: 602–613 (Oct.) 1953.
20.
HayesR. L.: Gallium-67 Localization in Rat and Mouse Tumors, Science167: 289–290 (Jan. 16) 1970.
21.
BichelP., and HansenH. H.: The Incorporation of 67Ga in Normal and Malignant Cells and Its Dependence on Growth Rate, Brit. J. Radiol.45: 182–184 (Mar.) 1972.
22.
HayesR. L.: Factors Affecting the Localization of 67Ga in Animal Tumors, (Abst) J. Nucl. Med.11: 324 (June) 1970.
23.
Personal Communication, New England Nuclear Corporation, Boston, Massachusetts.
24.
DudleyH. C., MunnJ. I., and HenryK. E.: Studies of the Metabolism of Gallium II. J. Pharmacol. Exp. Ther.98: 105–110 (Jan.) 1950.
25.
BurnerH. D., CooperB. M., and RehbockD. J.: A Study of Gallium IV: Toxicity of Gallium Citrate in Dogs and Rats, Radiology61: 550–555 (Oct.) 1953.
26.
AndrewsG. A., RootS. W., and KerhanH. D.: A Study of Gallium VI. Clinical Studies with Gallium,72Radiology61: 570–588 (Oct.) 1953.
27.
LarsonS. M.: Positive Gallium67 Photoscan in Myeloblastoma, J. Amer. Med. Assoc.222: 321–323 (Oct. 15) 1972.
28.
Gallium-67, as Gallium Citrate, Product Specification Sheet, Diagnostic Isotopes Incorporated, Upper Saddle River, New Jersey.